TNF alpha - Still a therapeutic target

Clinical and Translational Science

Volumn 1, Issue 2, 2008, Pages 145-

  Feldman, Arthur M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

APOPTOSIS; CALCIUM HOMEOSTASIS; CLINICAL TRIAL; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; GENE OVEREXPRESSION; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

CLINICAL TRIALS AS TOPIC; HEART FAILURE; HUMANS; IMMUNOGLOBULIN G; MODELS, ANIMAL; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953462809     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2008.00012.x     Document Type: Note

References (0)